查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829051

診斷影像設備市場（按產品類型、便攜性、應用和最終用戶分類）—2025-2032 年全球預測

Diagnostic Imaging Equipment Market by Product Type, Portability, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，診斷影像設備市場將成長至 717.7 億美元，複合年成長率為 6.09%。

主要市場統計數據
基準年2024年 447億美元
預計2025年 472.7億美元
預測年份：2032年 717.7億美元
複合年成長率（%） 6.09%

關於技術創新、臨床需求變化和業務需要如何改變診斷影像設備的採用和使用的權威概述

診斷影像仍然是現代臨床決策的支柱，它能夠在許多專業領域實現更早的發現、更準確的診斷和更完善的治療監測。雖然電腦斷層掃描、磁振造影造影、核子醫學影像、超音波和X光等影像方式仍然是治療途徑中不可或缺的，但不斷發展的臨床指南和技術進步正在日益影響著採購和使用模式。相關人員必須在複雜的環境中探索，必須在臨床有效性、病人安全、成本控制和工作流程最佳化之間取得平衡，才能創造可衡量的價值。

人口結構變化和慢性病的增加正在重新定義臨床需求，導致影像處理量不斷增加，並重新強調吞吐量和效率。同時，從硬體小型化到軟體驅動的影像增強等技術創新正在改變設備投資的價值提案。因此，醫療保健提供者和供應商不僅要考慮資本成本，還要考慮生命週期服務模式、與電子健康記錄的整合以及支援多學科護理的能力。有鑑於此，企業主管和臨床領導者需要清晰、基於證據地了解特定模式的進展、不斷變化的監管環境以及報銷壓力將如何影響他們未來的籌資策略和營運重點。

人工智慧、即時診斷模式、混合成像趨勢以及基於價值的指令將如何從根本上改變診斷成像格局

技術、臨床和經濟因素正在徹底改變診斷影像領域。人工智慧和先進的影像分析技術實現了自動分診、增強的病變檢測和定量生物標記，從而加快了診斷速度並提高了可重複性。同時，混合影像和多模態整合技術正在透過結合解剖和功能數據來提高臨床特異性，從而改變腫瘤學和神經病學的診斷演算法。

同時，以患者為中心的醫療服務模式正在縮小集中式放射科的規模，並推廣可攜式和床邊成像解決方案，使診斷能力更貼近床邊和社區環境。基於價值的報銷模式也在重塑採購和服務協議，供應商更重視可證明的療效、吞吐量和總擁有成本，而不僅僅是購置價格。最後，對輻射劑量最佳化、環境永續性和人體工學設計的日益關注正在影響產品開發和採購標準。因此，那些將產品藍圖與軟體主導的工作流程、互通性標準和靈活的商業模式相結合的公司，最有可能利用這些轉型變革。

評估近期關稅變化如何改變整個診斷影像設備價值鏈的供應鏈、採購決策和製造策略

美國將於2025年加徵關稅，這為全球診斷影像設備供應鏈和籌資策略帶來了新的複雜性。依賴跨境採購精密零件和半導體相關子系統的製造商面臨著不斷上升的投入成本和更長的前置作業時間，這迫使他們迅速重新評估供應商集中度風險。為此，許多公司加快了供應商多元化的步伐，在近岸生產關鍵次組件，並重新設計產品，以減少對受關稅影響零件的依賴。

由於成本壓力通常會透過供應鏈傳遞，醫療保健提供者和設備經銷商不得不重新協商採購條款和服務合約。資本投資委員會對總生命週期成本的影響以及短期資本支出與長期服務承諾之間的平衡變得更加敏感。同時，一些供應商尋求垂直整合和策略夥伴關係，以確保關鍵投入並穩定價格。監理合規和與關稅相關的行政負擔也隨之增加，凸顯了貿易專業知識在採購和合約簽訂中的重要性。整體而言，關稅環境已成為供應鏈韌性舉措、供應商關係重組和製造在地化策略加速推進的催化劑。

以細分為主導，對最終使用者採購行為提供獨特的觀點，影響模式差異化、可攜性權衡、臨床應用優先順序和策略定位

從產品類型、便攜性、應用和最終用戶維度解讀細分洞察，可以明確臨床需求和機會的交會點。按產品類型，電腦斷層掃描器不斷發展，分為高切片、中切和低切片影像，用途從進階截面血管檢查到常規緊急診斷。磁振造影分為針對高場強最佳化的封閉式系統和優先考慮患者舒適度和介入路徑的開放系統。核子造影分為 PET 和 SPECT，PET 在分子腫瘤學方面保持優勢，SPECT 則適用於更廣泛的心臟病學和功能性影像適應症。超音波具有廣泛的臨床效用，包括用於一般診斷的 2D 影像、推進產科和胎兒可視化的 3D 和 4D 平台以及增強血管和心臟血流評估的多普勒系統。 X 光系統繼續從類比平台過渡到數位射線，改善成像工作流程並與 PACS 和報告系統整合。

便攜性定義了另一個差異化維度：固定影像設備支援高通量集中式服務，而可攜式影像設備（從手持式到攜帶式設備）則支援在緊急情況和偏遠地區進行分散式診斷和快速回應。應用主導的細分揭示了與臨床領域相符的影像設備採用：循環系統利用冠狀動脈和血管成像進行干預計劃和隨訪；神經病學應用腦部和脊髓成像進行中風和退化性疾病管理；婦產科強調胎兒監護和盆腔成像；腫瘤科需要早期發現和分期以及持續監測；整形外科依賴於骨折檢測和以關節為中心的檢查。終端使用者細分同樣影響採購訂單和服務期望：門診醫療中心優先考慮經濟高效、快速週轉的系統；影像中心強調專業的通量和影像設備組合；醫院和診所尋求能夠處理各種急性和擇期手術的多功能整合平台。模式的選擇和配置直接影響臨床工作流程、人員配備和下游產生收入，因此了解這些部分的交集對於產品定位、資本規劃和臨床參與策略至關重要。

區域醫療保健基礎設施、監管分散和投資重點如何推動全球市場採用和商業策略的差異

區域動態對診斷成像產業的採用曲線、監管方法和創新傳播有重大影響。在美洲，完善的醫療基礎設施、整合的供應商佈局以及先進的報銷框架，支援高階醫療設備和整合軟體解決方案的快速普及。在歐洲、中東和非洲，監管碎片化和報銷環境的差異化導致了市場採用的不均衡趨勢：已開發國家更青睞先進的治療方法和高階設備，而其他市場則更青睞經濟高效、性能強大的解決方案。在某些地區，政策轉變和集中採購進一步影響了定價和競標行為。在亞太地區，醫療基礎設施投資、不斷成長的臨床需求以及有利的公共衛生舉措正在加速高階醫療設備和可攜式成像解決方案的普及，其中一些市場尤其熱衷於本地製造夥伴關係和增值服務。

區域供應鏈、臨床培訓的可近性以及患者的人口結構差異都會影響設備生命週期、服務模式和售後支援的結構。因此，跨區域營運的供應商和提供者必須根據當地的報銷情況和基礎設施限制，以客製化產品系列、資金籌措方案和臨床教育計畫。策略性的區域夥伴關係和靈活的上市模式對於將全球創新轉化為永續的本地應用，並降低監管變化和貿易中斷的風險至關重要。

深入分析現有企業、敏捷創新者和軟體顛覆者如何透過夥伴關係、服務和模組化產品策略來塑造競爭動態

診斷影像領域的競爭格局主要體現在：成熟的跨國製造商、利基市場創新者，以及越來越多專注於分析和工作流程最佳化的軟體參與企業。現有的設備製造商持續強調整合的軟硬體捆綁、生命週期服務協議以及融資解決方案，以減少大型供應商的實施阻力。同時，規模較小的公司和新興企業公司則憑藉專注的臨床應用、顛覆性的外形規格（例如掌上超音波）以及可部署為雲端服務的先進影像處理演算法，在競爭中脫穎而出。

策略夥伴關係、共同開發契約和定向收購已成為規模化和創新的主要槓桿。許多公司正在投資模組化架構，以實現功能增量升級，延長產品壽命，並透過軟體訂閱和臨床決策支援工具產生經常性收益。售後服務和設備託管計畫作為收入穩定的產品，正日益受到青睞，這些產品能夠將供應商的獎勵與提供者的執行時間和績效掛鉤。在競爭日益激烈的環境中，市場領導正在平衡資本密集型研發與臨床檢驗、培訓計畫和客戶成功團隊的上市時間承諾，以加速採用並獲得下游業務收益。

供應商和提供者應採取切實可行的優先策略行動，以創新、降低供應鏈風險，並使商業模式與臨床結果保持一致

產業領導者應採取多管齊下的策略，在創新與供應鏈韌性以及以客戶為中心的商業模式之間取得平衡。優先投資軟體和分析技術可以創造差異化的臨床價值，同時透過訂閱服務實現經常性收益。同時，多元化供應商基礎並評估近岸外包和區域製造夥伴關係可以降低貿易中斷和投入成本波動帶來的風險。領導者還應重新思考傳統的銷售方式，提供可配置的資金籌措、績效掛鉤合約以及全面的託管服務包，將獎勵與提供者的績效目標相結合。

在營運方面，建立強大的臨床檢驗計劃和以臨床醫生為中心的培訓可以加速技術應用並建立長期忠誠度。供應商團隊應投資於互通性和開放式架構設計，以簡化與異質醫院生態系統的整合，並支援多供應商工作流程。最後，隨著採購委員會越來越重視環境和病人安全，公司必須將永續性和劑量最佳化功能納入其產品藍圖。透過將技術創新與靈活的商業模式和彈性營運相結合，產業領導者可以實現策略成長，同時為客戶提供可衡量的臨床和財務價值。

結合相關人員訪談、臨床文獻分析和情境檢驗的穩健混合方法研究途徑可確保獲得可靠且可操作的見解

這些見解背後的調查方法融合了定性和定量的嚴謹性，並採用結構化方法，旨在對證據進行三角檢驗並確保可複製性。主要研究包括對臨床醫生、採購負責人、生物醫學工程師和行業高管的結構化訪談，提供有關醫療設備使用、維護週期和採購決策標準的第一線觀點。次要研究包括同行評審的臨床研究、監管指導文件、製造商技術規範和公開的財務資訊，以評估技術準備、臨床效用和營運限制。

數據合成採用交叉驗證技術來協調差異並識別共識趨勢。案例研究和實際實施情況的分析，總結了關於採用障礙和成功因素的經驗教訓。調查方法還結合了情境分析，以在不同監管和供應鏈條件下對策略假設進行壓力測試。研究發現，存在一些局限性，例如區域報銷實踐的差異以及軟體主導創新的動態性，並透過持續的相關人員參與和迭代檢驗週期來應對這些局限性，以保持研究的相關性和準確性。

簡明綜合了決定診斷影像領域競爭成功和臨床影響的技術、商業和政策因素

總體而言，診斷影像產業正處於曲折點，技術進步、醫療服務模式的轉變以及供應鏈現狀正在共同重新定義價值創造。軟體、影像分析和攜帶式硬體領域的創新正在釋放新的臨床用例，並支援分散式護理工作流程，而籌資策略也擴大以總體擁有成本、與臨床結果的關聯性以及服務的連續性為導向。貿易政策和關稅的變化凸顯了供應鏈多元化的重要性，加速了與區域製造業的對話，並為採購和產品設計決策增添了策略層面。

成功將產品創新與彈性運作、靈活的商業性框架和以臨床醫生為中心的實施計劃相結合的組織將獲得競爭優勢。此外，檢驗臨床效果、確保跨司法管轄區的法規合規性以及提供可靠的售後服務的能力將決定長期的供應商-提供者關係。隨著該領域的不斷發展，相關人員應保持敏捷的投資組合規劃，並優先考慮能夠在不同醫療環境中帶來顯著臨床效益和營運效率的投資。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將人工智慧驅動的影像分析軟體整合到診斷成像工作流程中，以提高準確性和效率
  • 快速採用光子計數 CT 掃描儀來提高空間解析度並減少輻射劑量
  • 開發可攜式和手持式超音波設備，實現遠端地點的照護現場診斷
  • 混合 PET/MRI 系統在腫瘤學中擴大用於同時代謝和結構成像
  • 透過安全的資料共用和人工智慧診斷支援工具擴展雲端基礎的PACS 解決方案

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：診斷影像設備市場（依產品類型）

  • 電腦斷層掃描（CT）掃描儀
    • 高切CT掃描儀
    • 低切片CT掃描儀
    • 中切CT掃描儀
  • 磁振造影（MRI）設備
    • 封閉式MRI系統
    • 開放式磁振造影系統
  • 核子造影設備
    • PET系統
    • SPECT 系統
  • 超音波系統
    • 2D超音波系統
    • 3D和4D超音波系統
    • 多普勒超音波系統
  • X光系統
    • 模擬X光系統
    • 數位X光系統

第 9 章：診斷影像設備市場（按便攜性）

  • 固定成像設備
  • 可攜式成像設備
    • 手持行動裝置
    • 可運輸設備

第 10 章：診斷影像設備市場（按應用）

  • 心臟病學
    • 冠狀動脈成像
    • 血管影像
  • 神經病學
    • 腦部掃描
    • 脊髓影像檢查
  • 婦產科
    • 胎兒監護
    • 骨盆腔影像檢查
  • 腫瘤學
    • 早期檢測
    • 分期和監控
  • 整形外科
    • 骨折檢測
    • 聯合考試

第 11 章：診斷影像設備市場（按最終用戶）

  • 門診治療中心
  • 診斷影像中心
  • 醫院和診所

第 12 章：按地區分類的診斷影像設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：診斷影像設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國診斷影像設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Agfa-Gevaert Group
    • Analogic Corporation
    • Avonix Imaging, LLC by Nikon Corporation
    • Barco NV
    • Bracco SpA
    • Canon Medical Systems Corporation
    • Carestream Health, Inc.
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE HealthCare Technologies Inc.
    • Hologic, Inc.
    • Konica Minolta, Inc.
    • Koninklijke Philips NV
    • Medtronic PLC
    • MinFound Medical Systems Co., Ltd.
    • Neusoft Corporation
    • Planmed Oy
    • Samsung Electronics Co., Ltd
    • Shanghai United Imaging Healthcare Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
    • Shimadzu Corporation
    • Siemens Healthineers
    • Stryker Corporation
    • Ziehm Imaging GmbH
Product Code: MRR-43676CF420BD

The Diagnostic Imaging Equipment Market is projected to grow by USD 71.77 billion at a CAGR of 6.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 44.70 billion
Estimated Year [2025] USD 47.27 billion
Forecast Year [2032] USD 71.77 billion
CAGR (%) 6.09%

An authoritative overview of how technological innovation, clinical demand shifts, and operational imperatives are reshaping diagnostic imaging equipment adoption and use

Diagnostic imaging equipment continues to serve as the backbone of modern clinical decision-making, enabling earlier detection, more accurate diagnoses, and better treatment monitoring across a broad range of specialties. Imaging modalities such as computed tomography, magnetic resonance imaging, nuclear imaging, ultrasound, and X-ray remain integral to care pathways, while evolving clinical guidelines and technological advances are increasingly shaping procurement and utilization patterns. Stakeholders are navigating a complex environment where clinical efficacy, patient safety, cost containment, and workflow optimization must be balanced to deliver measurable value.

Clinical demands are being redefined by a confluence of demographic shifts and rising chronic disease prevalence, which together increase imaging volumes and place renewed emphasis on throughput and efficiency. At the same time, technological innovations-ranging from hardware miniaturization to software-driven image enhancement-are altering the value proposition of equipment investments. Providers and vendors must therefore consider not only capital cost but also lifecycle service models, integration with electronic health records, and the ability to support multidisciplinary care. Given this landscape, executives and clinical leaders need a clear, evidence-based picture of how modality-specific advances, regulatory changes, and reimbursement pressures will influence procurement strategies and operational priorities going forward.

How artificial intelligence, point-of-care modalities, hybrid imaging trends, and value-based imperatives are fundamentally altering the diagnostic imaging landscape

The diagnostic imaging landscape is undergoing fundamental transformation driven by converging technological, clinical, and economic forces. Artificial intelligence and advanced image analytics are enabling automated triage, enhanced lesion detection, and quantitative biomarkers that can accelerate diagnosis while improving reproducibility. Concurrently, hybrid imaging and multimodal integration are increasing clinical specificity by combining anatomical and functional data, which is transforming diagnostic algorithms in oncology and neurology.

Meanwhile, the push toward patient-centric care is promoting portable and point-of-care imaging solutions that decongest centralized radiology suites and bring diagnostic capability closer to bedside and community settings. Value-based reimbursement models are also reshaping purchase and service contracts, with providers placing greater emphasis on demonstrable outcomes, throughput, and total cost of ownership rather than acquisition price alone. Lastly, an increased focus on radiation dose optimization, environmental sustainability, and ergonomic design is influencing both product development and procurement criteria. As a result, companies that align product roadmaps with software-driven workflows, interoperability standards, and flexible commercial models are best positioned to capitalize on these transformative shifts.

Assessing how recent tariff shifts have reshaped supply chains, procurement decisions, and manufacturing strategies across the diagnostic imaging equipment value chain

The implementation of tariffs by the United States in 2025 introduced a new layer of complexity to global diagnostic imaging supply chains and procurement strategies. Manufacturers that relied on cross-border sourcing for precision components and semiconductor-dependent subsystems faced increased input costs and longer lead times, prompting rapid reassessment of supplier concentration risks. In response, many organizations accelerated efforts to diversify suppliers, nearshore production of critical subassemblies, and redesign products to reduce dependence on tariff-impacted parts.

Healthcare providers and equipment distributors experienced pressure to renegotiate purchase terms and service agreements, as cost pressures were often transferred through the supply chain. Capital expenditure committees became more sensitive to total lifecycle cost implications and to the balance between immediate capital outlay and long-term service commitments. At the same time, some vendors pursued vertical integration and strategic partnerships to secure critical inputs and stabilize pricing. Regulatory compliance and customs-related administrative burdens also increased, raising the importance of trade expertise in procurement and contracting. Overall, the tariff environment catalyzed supply chain resilience initiatives, reshaping vendor relationships and accelerating manufacturing localization strategies that will influence procurement negotiation dynamics and product roadmaps in the medium term.

Distinctive segmentation-driven perspectives on modality differentiation, portability trade-offs, clinical application priorities, and end-user procurement behaviors influencing strategic positioning

Interpreting segmentation insights across product type, portability, application, and end-user dimensions provides clarity on where clinical needs and commercial opportunity intersect. Within product categories, computed tomography systems continue to evolve with distinctions between high-slice, mid-slice, and low-slice systems shaping use cases from advanced cross-sectional vascular studies to routine emergency diagnostics. Magnetic resonance imaging equipment remains divided between closed systems optimized for higher field strengths and open systems that prioritize patient comfort and interventional access. Nuclear imaging splits across PET and SPECT modalities, with PET maintaining strength in molecular oncology and SPECT serving broader cardiology and functional imaging indications. Ultrasound retains broad clinical utility with 2D imaging for general diagnostics, 3D and 4D platforms advancing obstetrical and fetal visualization, and Doppler systems enhancing vascular and cardiac flow assessment. X-ray systems continue their transition from analog platforms to digital radiography, improving image workflow and integration with PACS and reporting systems.

Portability defines a separate axis of differentiation, where fixed imaging equipment supports high-throughput centralized services while portable imaging equipment, spanning handheld devices and transportable units, enables decentralized diagnostics and rapid response in emergency or remote settings. Application-driven segmentation reveals modality adoption aligned to clinical domains: cardiology leverages coronary and vascular imaging for interventional planning and follow-up, neurology applies brain and spinal cord imaging for stroke and degenerative disease management, obstetrics and gynecology emphasize fetal monitoring and pelvic imaging, oncology requires early detection and staging plus ongoing monitoring, and orthopedics depends on fracture detection and joint-focused examinations. End-user segmentation likewise informs procurement cadence and service expectations; ambulatory care centers prioritize cost-effective, rapid turnaround systems, diagnostic imaging centers focus on specialized throughput and modality mix, and hospitals and clinics demand versatile, integrated platforms capable of supporting a wide range of acute and elective procedures. Understanding these segment intersections is critical for product positioning, capital planning, and clinical engagement strategies, as modality choice and configuration directly influence clinical workflow, staffing, and downstream revenue generation.

How regional healthcare infrastructure, regulatory fragmentation, and investment priorities are directing differential adoption and commercial strategies across global markets

Regional dynamics exert significant influence on adoption curves, regulatory approaches, and innovation diffusion across the diagnostic imaging industry. In the Americas, established healthcare infrastructure, consolidated vendor footprints, and advanced reimbursement frameworks support rapid uptake of high-end modalities and integrated software solutions, while systems procurement is often tied to demonstrated clinical outcomes and vendor service quality. In Europe, the Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement environments create a patchwork of adoption, where advanced therapies and high-end devices perform strongly in developed pockets while other markets emphasize cost-effective, robust solutions. Policy shifts and centralized purchasing in some jurisdictions further influence pricing and tendering behaviors. In the Asia-Pacific region, investment in healthcare infrastructure, rising clinical demand, and favorable public health initiatives are driving accelerated adoption of both high-end modalities and portable imaging solutions, with several markets showing particular appetite for localized manufacturing partnerships and value-aligned service offerings.

Cross-region supply chain considerations, clinical training availability, and variations in patient demographics all shape how device lifecycles, service models, and aftermarket support are structured. Vendors and providers operating across regions must therefore calibrate product portfolios, financing options, and clinical education programs to local reimbursement realities and infrastructure constraints. Strategic regional partnerships and adaptable go-to-market models are essential to translate global innovation into sustainable regional adoption and to mitigate risks associated with regulatory changes and trade disruptions.

An incisive view of how incumbent manufacturers, nimble innovators, and software disruptors are shaping competitive dynamics through partnerships, services, and modular product strategies

The competitive landscape in diagnostic imaging is characterized by a mix of established multinational manufacturers, specialized niche innovators, and a growing cohort of software-first entrants focused on analytics and workflow optimization. Incumbent device manufacturers continue to emphasize integrated hardware-software bundles, lifecycle service agreements, and financing solutions that reduce adoption friction for large providers. Simultaneously, smaller firms and startups are carving out differentiation through focused clinical applications, disruptive form factors such as handheld ultrasound, and advanced image processing algorithms that can be deployed as cloud-enabled services.

Strategic partnerships, co-development agreements, and targeted acquisitions have emerged as primary levers for both scale and innovation. Many companies are investing in modular architectures that allow incremental feature upgrades, thereby extending product lifespans and creating recurring revenue through software subscriptions and clinical decision support tools. Aftermarket services and managed equipment programs are gaining prominence as revenue-stable offerings that align vendor incentives with provider uptime and performance. As competition intensifies, market leaders are balancing capital-intensive R&D with go-to-market investments in clinical validation, training programs, and customer success teams to accelerate adoption and capture downstream service revenue.

Practical and prioritized strategic actions that vendors and providers should implement to innovate, de-risk supply chains, and align commercial models with clinical outcomes

Industry leaders should adopt a multi-faceted strategy that balances innovation with supply chain resilience and customer-centric commercial models. Prioritizing investments in software and analytics can create differentiated clinical value while enabling recurring revenue through subscription services. At the same time, diversifying supplier bases and evaluating nearshoring or regional manufacturing partnerships will mitigate exposure to trade disruptions and input-cost volatility. Leaders should also reconsider traditional sales approaches by offering configurable financing, outcome-linked contracts, and comprehensive managed-service packages that align incentives with provider performance goals.

Operationally, building strong clinical validation programs and clinician-focused training will accelerate technology adoption and build long-term loyalty. Vendor teams should invest in interoperability and open-architecture designs to ease integration into heterogeneous hospital ecosystems and to support multi-vendor workflows. Finally, companies must integrate sustainability and dose-optimization features into product roadmaps as procurement committees increasingly weigh environmental and patient-safety credentials. By combining technical innovation with flexible commercial models and resilient operations, industry leaders can capture strategic growth while delivering measurable clinical and financial value to customers.

A robust mixed-methods research approach combining stakeholder interviews, clinical literature analysis, and scenario validation to ensure reliable and actionable insights

The research underpinning these insights blended qualitative and quantitative rigor through a structured methodology designed to triangulate evidence and ensure reproducibility. Primary research included structured interviews with clinicians, procurement officers, biomedical engineers, and industry executives, providing frontline perspectives on modality utilization, maintenance cycles, and purchase decision criteria. Secondary research encompassed peer-reviewed clinical studies, regulatory guidance documents, manufacturer technical specifications, and publicly available financial disclosures, which together informed assessments of technology readiness, clinical utility, and operational constraints.

Data synthesis employed cross-validation techniques to reconcile divergent views and to identify consensus trends. Case studies and real-world implementations were analyzed to extract lessons on deployment barriers and success factors. The methodology also incorporated scenario analysis to stress-test strategic assumptions under differing regulatory and supply chain conditions. Limitations were acknowledged, including variations in local reimbursement practices and the dynamic nature of software-driven innovation, and these were addressed through continuous stakeholder engagement and iterative validation cycles to maintain relevance and accuracy.

A concise synthesis of the converging technological, operational, and policy forces that will determine competitive success and clinical impact in diagnostic imaging

In synthesis, the diagnostic imaging equipment sector is at an inflection point where technological advances, shifting care delivery models, and supply chain realities are jointly redefining value creation. Innovations in software, image analytics, and portable hardware are unlocking new clinical use cases and enabling decentralized care workflows, while procurement strategies are increasingly guided by total cost of ownership, clinical outcome linkage, and service continuity. Trade policy and tariff changes have underscored the importance of supply chain diversification and have accelerated regional manufacturing conversations, adding a strategic layer to procurement and product design decisions.

Organizations that successfully integrate product innovation with resilient operations, flexible commercial frameworks, and clinician-centered implementation plans will gain competitive advantage. Moreover, the ability to validate clinical impact, ensure regulatory compliance across jurisdictions, and provide reliable aftermarket services will determine long-term vendor-provider relationships. As the sector continues to evolve, stakeholders should maintain agility in portfolio planning and prioritize investments that deliver demonstrable clinical benefit and operational efficiency across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven image analysis software in diagnostic imaging workflows to improve accuracy and efficiency
  • 5.2. Rapid adoption of photon-counting CT scanners for enhanced spatial resolution and reduced radiation dose
  • 5.3. Development of portable and handheld ultrasound devices enabling point-of-care diagnostics in remote settings
  • 5.4. Increasing deployment of hybrid PET/MRI systems for simultaneous metabolic and structural imaging in oncology
  • 5.5. Expansion of cloud-based PACS solutions with secure data sharing and AI-powered diagnostic support tools

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Equipment Market, by Product Type

  • 8.1. Computed Tomography (CT) Scanners
    • 8.1.1. High-Slice CT Scanners
    • 8.1.2. Low-Slice CT Scanners
    • 8.1.3. Mid-Slice CT Scanners
  • 8.2. Magnetic Resonance Imaging (MRI) Equipment
    • 8.2.1. Closed MRI Systems
    • 8.2.2. Open MRI Systems
  • 8.3. Nuclear Imaging Equipment
    • 8.3.1. PET Systems
    • 8.3.2. SPECT Systems
  • 8.4. Ultrasound Systems
    • 8.4.1. 2D Ultrasound Systems
    • 8.4.2. 3D & 4D Ultrasound Systems
    • 8.4.3. Doppler Ultrasound Systems
  • 8.5. X-Ray Systems
    • 8.5.1. Analog X-Ray Systems
    • 8.5.2. Digital X-Ray Systems

9. Diagnostic Imaging Equipment Market, by Portability

  • 9.1. Fixed Imaging Equipment
  • 9.2. Portable Imaging Equipment
    • 9.2.1. Handheld Portable Devices
    • 9.2.2. Transportable Equipment

10. Diagnostic Imaging Equipment Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Coronary Imaging
    • 10.1.2. Vascular Imaging
  • 10.2. Neurology
    • 10.2.1. Brain Scans
    • 10.2.2. Spinal Cord Imaging
  • 10.3. Obstetrics & Gynecology
    • 10.3.1. Fetal Monitoring
    • 10.3.2. Pelvic Imaging
  • 10.4. Oncology
    • 10.4.1. Early Detection
    • 10.4.2. Staging & Monitoring
  • 10.5. Orthopedics
    • 10.5.1. Fracture Detection
    • 10.5.2. Joint Examination

11. Diagnostic Imaging Equipment Market, by End-User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals & Clinics

12. Diagnostic Imaging Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Diagnostic Imaging Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Diagnostic Imaging Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Agfa-Gevaert Group
    • 15.3.2. Analogic Corporation
    • 15.3.3. Avonix Imaging, LLC by Nikon Corporation
    • 15.3.4. Barco NV
    • 15.3.5. Bracco S.p.A.
    • 15.3.6. Canon Medical Systems Corporation
    • 15.3.7. Carestream Health, Inc.
    • 15.3.8. Esaote S.p.A
    • 15.3.9. FUJIFILM Holdings Corporation
    • 15.3.10. GE HealthCare Technologies Inc.
    • 15.3.11. Hologic, Inc.
    • 15.3.12. Konica Minolta, Inc.
    • 15.3.13. Koninklijke Philips N.V.
    • 15.3.14. Medtronic PLC
    • 15.3.15. MinFound Medical Systems Co., Ltd.
    • 15.3.16. Neusoft Corporation
    • 15.3.17. Planmed Oy
    • 15.3.18. Samsung Electronics Co., Ltd
    • 15.3.19. Shanghai United Imaging Healthcare Co., Ltd.
    • 15.3.20. Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • 15.3.21. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
    • 15.3.22. Shimadzu Corporation
    • 15.3.23. Siemens Healthineers
    • 15.3.24. Stryker Corporation
    • 15.3.25. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. DIAGNOSTIC IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. DIAGNOSTIC IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2024 (USD MILLION)

TABLE